BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31330140)

  • 1. Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide.
    Lu J; Yu K; Fan S; Liu W; Dong Z; Li J; Wang X; Hai X; Zhou J
    Toxicol Appl Pharmacol; 2019 Sep; 379():114687. PubMed ID: 31330140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in arsenic (+ 3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with As
    Liu WS; Wang XY; Lu J; Zhang YM; Ye XM; Li JM; Zhao QL; Wu ZQ; Zhou J; Hai X
    Arch Toxicol; 2020 Apr; 94(4):1203-1213. PubMed ID: 32112223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AS3MT Polymorphisms, Arsenic Metabolism, and the Hematological and Biochemical Values in APL Patients Treated with Arsenic Trioxide.
    Lu J; Hu S; Wang W; Li J; Dong Z; Zhou J; Hai X
    Toxicol Sci; 2018 Nov; 166(1):219-227. PubMed ID: 30376134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
    Zhao Q; Guo M; Hostetter TH; Chen H; Lin L; Hai X
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1173-1182. PubMed ID: 34181499
    [No Abstract]   [Full Text] [Related]  

  • 5. Arsenic metabolism, N6AMT1 and AS3MT single nucleotide polymorphisms, and their interaction on gestational diabetes mellitus in Chinese pregnant women.
    Liang X; Guo G; Wang Y; Wang M; Chen X; Zhang J; Li S; Liu L; Huang Q; Cui B; Zhang M; Sun G; Tang N; Zhang X; Zhang Q
    Environ Res; 2023 Mar; 221():115331. PubMed ID: 36681142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between arsenic (+3 oxidation state) methyltransferase gene polymorphisms and arsenic methylation capacity in rural residents of northern China: a cross-sectional study.
    Zhang M; Xu H; Lou Q; Zhang Z; Zhang X; Yin F; Lv M; Zhang Y; Yin Y; Gao Y; Liu X; Yang Y
    Arch Toxicol; 2023 Nov; 97(11):2919-2928. PubMed ID: 37658865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Guo S; Wang X; Gao C; Wu Z; Chen H; Lin L; Guo M; Gao Y; Hai X
    Toxicol Lett; 2021 Sep; 347():78-85. PubMed ID: 33865921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer.
    Lin YC; Chen WJ; Huang CY; Shiue HS; Su CT; Ao PL; Pu YS; Hsueh YM
    Toxicol Sci; 2018 Jul; 164(1):328-338. PubMed ID: 29669044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
    Guo M; Wang B; Liu S; Wang W; Gao C; Hu S; Fan S; Hai X; Zhou J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):371-378. PubMed ID: 30795697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genetic polymorphisms on arsenic methylation efficiency during pregnancy: Evidence from a Spanish birth cohort.
    Soler-Blasco R; Harari F; Riutort-Mayol G; Murcia M; Lozano M; Irizar A; Marina LS; Zubero MB; Fernández-Jimenez N; Braeuer S; Ballester F; Llop S
    Sci Total Environ; 2023 Nov; 900():165740. PubMed ID: 37495132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.
    Khaleghian A; Ghaffari SH; Ahmadian S; Alimoghaddam K; Ghavamzadeh A
    J Cell Biochem; 2014 Oct; 115(10):1729-39. PubMed ID: 24819152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China.
    Chen X; Guo X; He P; Nie J; Yan X; Zhu J; Zhang L; Mao G; Wu H; Liu Z; Aga D; Xu P; Smith M; Ren X
    Toxicol Sci; 2017 Jan; 155(1):124-134. PubMed ID: 27637898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide.
    Zheng Y; Mao YF; Zhao HJ; Chen L; Wang LN; Zhang YX; Hu J; Li JM; Li XY; Zhu HM
    Exp Hematol Oncol; 2021 Feb; 10(1):10. PubMed ID: 33549147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the AS3MT gene are associated with arsenic methylation capacity and damage to the P21 gene in arsenic trioxide plant workers.
    Ni G; Tan J; Wang M; Ping N; Liu M; He Y
    Toxicol Ind Health; 2021 Dec; 37(12):727-736. PubMed ID: 34730462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Wang X; Qian Z; Li H; Chen H; Lin L; Guo M; Hai X
    J Pharm Biomed Anal; 2021 Sep; 203():114201. PubMed ID: 34130006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
    Gao C; Lin L; Li J; Wu M; Lv J; Tian S; Hai X
    Toxicol Lett; 2023 May; 380():31-39. PubMed ID: 37024065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenite methyltransferase (AS3MT) polymorphisms and arsenic methylation in children in rural Bangladesh.
    De Loma J; Skröder H; Raqib R; Vahter M; Broberg K
    Toxicol Appl Pharmacol; 2018 Oct; 357():80-87. PubMed ID: 30153448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam.
    Agusa T; Iwata H; Fujihara J; Kunito T; Takeshita H; Minh TB; Trang PT; Viet PH; Tanabe S
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):131-41. PubMed ID: 19371612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients.
    Lv J; Wu M; Pang C; Duan R; Zhang H; Tian S; Yang H; Hai X
    Biomed Pharmacother; 2023 Jul; 163():114858. PubMed ID: 37172335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility.
    Antonelli R; Shao K; Thomas DJ; Sams R; Cowden J
    Environ Res; 2014 Jul; 132():156-67. PubMed ID: 24792412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.